Estrella Immunopharma, Inc. — Investor Relations & Filings
Filings indexed
240
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
ESLA
Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing T-cell immunotherapies for cancer and autoimmune diseases. The company's proprietary technology is the ARTEMIS® (Affinity-optimized T-cell Receptor Engineered for Minimal Signaling) T-cell platform. Its pipeline is centered on developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat blood cancers and solid tumors. Estrella aims to translate scientific innovations into next-generation cell therapies to address significant treatment challenges and improve patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K/A - Estrella Immunopharma, Inc. (0001844417) (Filer) | 2026-04-30 | English | |
| 424B3 Filing | 2026-02-13 | English | |
| Regulatory Filings 2026 | 2026-01-26 | English | |
| REGISTRATION STATEMENT | 2026-01-22 | English | |
| REGISTRATION STATEMENT | 2026-01-16 | English | |
| CURREN REPORT | 2026-01-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 39236586 | 10-K/A - Estrella Immunopharma, Inc. (0001844417) (Filer) | 2026-04-30 | English | ||
| 32036622 | 424B3 Filing | 2026-02-13 | English | ||
| 13375912 | Regulatory Filings 2026 | 2026-01-26 | English | ||
| 13375911 | REGISTRATION STATEMENT | 2026-01-22 | English | ||
| 13375913 | REGISTRATION STATEMENT | 2026-01-16 | English | ||
| 13375914 | CURREN REPORT | 2026-01-13 | English | ||
| 13375915 | CURRENT REPORT | 2026-01-06 | English | ||
| 13375916 | PROSPECTUS SUPPLEMENT | 2026-01-06 | English | ||
|
2025
7 filings
| |||||
| 13375917 | REGISTRATION STATEMENT | 2025-12-22 | English | ||
| 13375918 | CURRENT REPORT | 2025-12-04 | English | ||
| 13375919 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 13375920 | CURRENT REPORT | 2025-11-06 | English | ||
| 13375921 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13375922 | CURRENT REPORT | 2025-09-29 | English | ||
| 13375923 | CURRENT REPORT | 2025-09-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Estrella Immunopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34647/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34647 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34647 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34647 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34647}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Estrella Immunopharma, Inc. (id: 34647)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.